top of page

AOC And Ilhan Omar Blast DEA Head’s ‘Boomer’ Claims That Marijuana Is A Harmful Gateway Drug

  • Writer: Bob Marley
    Bob Marley
  • Jan 24, 2025
  • 3 min read

Two Democratic congresswomen are calling out the Trump administration’s new head of the Drug Enforcement Administration (DEA) over past comments he’s made about marijuana that reflect a “boomer” mentality, including his claim that cannabis is a gateway drug and that the ongoing rescheduling push is politically motivated.

In interviews with Marijuana Moment on Thursday, Reps. Alexandria Ocasio-Cortez (D-NY) and Ilhan Omar (D-MN) were asked about the recent announcement that Derek Maltz would be returning from retirement to serve as DEA’s acting administrator.

The official has made a series of sensational claims about marijuana, calling it a gateway drug that sets children up to use other substances, suggesting marijuana use is linked to school shootings and alleging that the Justice Department “hijacked” the cannabis rescheduling process from DEA, for example.

“What is he 100 years old? All of that has been debunked for a really long time, and I think it’s such a boomer thing to say,” Omar, who was recently appointed to serve as co-chair of the Congressional Cannabis Caucus, said. “I don’t know how old this man is.”

“First of all, we’re not advocating for legalization so kids can use it. So I don’t know why he’s talking about kids,” she said. “It’s helpful for a lot of people who are struggling with all types of stuff.”

Ocasio-Cortez was also asked to weigh in on the new administrator’s past comments, and she said if Maltz is concerned about potential health risks from cannabis, “then maybe he should deschedule marijuana so it can be freely studied.”

“Does he have a medical degree? He doesn’t even have a medical degree,” the congresswoman said, adding that “we can also learn from states that have not criminalized marijuana but have treated it as a substance, the same as alcohol and many other substances as well.”

Maltz, who retired from the agency in 2014 after 28 years of service, has also suggested that state-regulated marijuana markets don’t mitigate illicit sales because “people aren’t going to pay for marijuana…with these high taxes in these states [that have legalized].”

Maltz has been particularly critical of the current marijuana rescheduling effort, claiming that the Justice Department “hijacked” the process from DEA when it advanced a recommendation from the U.S. Department of Health and Human Services (HHS) to move cannabis from Schedule I to Schedule III of the Controlled Substances Act (CSA).

Historically it has been the DEA administrator to sign off on drug scheduling moves, but in this case the cannabis proposed rule was signed by then-Attorney General Merrick Garland.

“It sure seems to me that DOJ has prioritized politics and votes over public health and safety!” he said last May.

Whoever ultimately assumes the top DEA position will be inheriting the years-long rulemaking process to reschedule marijuana initiated under the Biden administration, so advocates and stakeholders are closely following to see who might fill that role.

The announcement that Maltz will be serving as acting administrator comes as another former agency official, Jack Riley, says he’s being courted to potentially lead DEA under the newly inaugurated Trump administration. Riley has previously described marijuana as a “gateway drug.”

For now, administrative hearings on the rescheduling proposal that were scheduled to begin on Tuesday have been delayed, with an agency judge recently granting an appeal motion from pro-reform witnesses that will set the clock back at least three months amid allegations of improper communications between DEA and rescheduling opponents and more.

Trump initially chose Hillsborough County, Florida Sheriff Chad Chronister to lead DEA, but the prospective nominee—who strongly advocated for marijuana decriminalization—withdrew from consideration last month amid scrutiny from conservative lawmakers over the sheriff’s record on COVID-related public safety enforcement actions.

Meanwhile, Trump’s choice for U.S. attorney general, former Florida Attorney General Pam Bondi (R), is declining to say how she plans to navigate key marijuana policy issues—including the ongoing rescheduling process and renewing federal enforcement guidance—if she’s ultimately confirmed.

The LCB contributed reporting from Washington, D.C. 

Elizabeth Warren Pushes Elon Musk To Cut Federal Marijuana Enforcement Through New DOGE Agency

Comments


Global SEO Keywords

marihuana, cannabis, cáñamo, CBD, aceite de CBD, bálsamo de CBD, marijuana, hemp, weed, CBD oil, CBD balm, canapa, erba, olio di CBD, balsamo CBD, chanvre, herbe, huile de CBD, baume CBD, Marihuana, Cannabis, Hanf, Gras, CBD Öl, CBD Balsam, maconha, cânhamo, erva, óleo de CBD, bálsamo CBD, hennep, wiet, CBD olie, CBD balsem, hampa, gräs, CBD olja, CBD balsam, hamp, græs, gress, CBD olje, hamppu, ruoho, CBD öljy, CBD balsami, konopie, konopie indyjskie, olej CBD, balsam CBD, konopí, CBD olej, CBD balzám, konope, CBD balzam, marihuána, kannabisz, kender, fű, CBD olaj, CBD balzsam, canabis, cânepă, iarbă, ulei CBD, марихуана, канабис, коноп, CBD масло, CBD балсам, μαριχουάνα, κάνναβη, χασίς, λάδι CBD, βάλσαμο CBD, kanabis, konoplja, trava, CBD ulje, CBD olje, kanapės, kanapės indinės, CBD aliejus, CBD balzamas, marihuāna, kaņepes, CBD eļļa, CBD balzams, marihuaana, kanep, CBD õli, CBD palsam, kannabis, qanneb, żejt CBD, balsam CBD, marijúna, hampur, CBD olía, CBD smyrsl

Disclaimer

Jacob Hooy CBD Lip Balm is free from parabens and artificial colorants and contains no toxins or heavy metals, supporting natural body care. Our products are not intended to diagnose, treat, cure, or prevent any disease, medical condition, or symptom. The information provided on this website is for informational purposes only and must not be considered medical advice, nor a substitute for professional diagnosis, treatment, or guidance provided by qualified physicians, healthcare professionals, or pharmaceutical specialists. Nothing on this website should be interpreted as a recommendation, prescription, or therapeutic claim.

Difresh Spain is an online retail store registered under IAE Group 652.3, specializing in the retail trade of perfumery, cosmetic products, and personal hygiene and care items. NIF: Y3526859-F. E-mail: info@cbdvending.eu - WhatsApp: +34662918154 - Factory adress: Calle Albardín 13, Nave B07, 50720, La cartuja baja, Zaragoza, España. All prices include VAT and free shipping across all European Union countries.

© 2026 - www.cbdvending.euPrivacy Policy

bottom of page